Buy Cellectar Wts 19 Stock | CLRBW Stock Price & Latest News | Public
CLRBW

Cellectar Wts 19

    We couldn’t load this chart.

    Some stock charts might currently not be supported. To try again, please refresh this page.

    About CLRBW

    Cellectar BioSciences, Inc. engages in the development of phospholipid drug conjugates (PDCs) for the treatment and imaging of cancer. Its portfolio includes CLR 131, which seeks to treat relapse or refractory multiple myeloma; CLR 125, which intends to treat micro meta...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    Stats

    Market Cap
    Volume
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High
    1 Year Low
    Open
    High
    Low

    Buy any stock with any amount of money.

    Download the App
    Download the app